185 related articles for article (PubMed ID: 19759250)
21. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
[No Abstract] [Full Text] [Related]
22. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
23. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W
Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
[TBL] [Abstract][Full Text] [Related]
24. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
[TBL] [Abstract][Full Text] [Related]
25. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
[TBL] [Abstract][Full Text] [Related]
26. Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.
Garmory HS; Titball RW; Griffin KF; Hahn U; Böhm R; Beyer W
Infect Immun; 2003 Jul; 71(7):3831-6. PubMed ID: 12819066
[TBL] [Abstract][Full Text] [Related]
27. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
28. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
29. Protective antigen domain 4 of
Żakowska D; Graniak G; Rutyna P; Naylor K; Głowacka P; Niemcewicz M
Ann Agric Environ Med; 2019 Sep; 26(3):392-395. PubMed ID: 31559791
[TBL] [Abstract][Full Text] [Related]
30. Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.
Brahmbhatt TN; Darnell SC; Carvalho HM; Sanz P; Kang TJ; Bull RL; Rasmussen SB; Cross AS; O'Brien AD
Infect Immun; 2007 Nov; 75(11):5240-7. PubMed ID: 17785478
[TBL] [Abstract][Full Text] [Related]
31. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
Fasanella A; Tonello F; Garofolo G; Muraro L; Carattoli A; Adone R; Montecucco C
Vaccine; 2008 Oct; 26(45):5684-8. PubMed ID: 18775462
[TBL] [Abstract][Full Text] [Related]
32. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
[TBL] [Abstract][Full Text] [Related]
33. Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.
Mamedov T; Chichester JA; Jones RM; Ghosh A; Coffin MV; Herschbach K; Prokhnevsky AI; Streatfield SJ; Yusibov V
PLoS One; 2016; 11(4):e0153956. PubMed ID: 27101370
[TBL] [Abstract][Full Text] [Related]
34. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
[TBL] [Abstract][Full Text] [Related]
35. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
[TBL] [Abstract][Full Text] [Related]
36. Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination.
Cao S; Guo A; Liu Z; Tan Y; Wu G; Zhang C; Zhao Y; Chen H
Infect Immun; 2009 Oct; 77(10):4679-87. PubMed ID: 19620345
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM
FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653
[TBL] [Abstract][Full Text] [Related]
38. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
Yan M; Roehrl MH; Basar E; Wang JY
Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
[TBL] [Abstract][Full Text] [Related]
39. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
Price BM; Liner AL; Park S; Leppla SH; Mateczun A; Galloway DR
Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
[TBL] [Abstract][Full Text] [Related]
40. Rabies virus glycoprotein as a carrier for anthrax protective antigen.
Smith ME; Koser M; Xiao S; Siler C; McGettigan JP; Calkins C; Pomerantz RJ; Dietzschold B; Schnell MJ
Virology; 2006 Sep; 353(2):344-56. PubMed ID: 16820183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
